verified SJR 3,039 · Q1 • database Scopus / SJR & Web of Science indexed

United States · Lippincott Williams and Wilk...

workspace_premium Q1 — Cardiology and Cardiovascular Medicine lock Subscription

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions is a journal indexed in SJR in Cardiology and Cardiovascular Medicine with an H index of 122. It has an SJR impact factor of 3,039 and it has a best quartile of Q1. It has an SJR impact factor of 3,039.

Circulation: Cardiovascular Interventions focuses its scope in these topics and keywords: coronary, patients, flow, undergoing, treatment, fractional, outcomes, artery, percutaneous, administrative, ...

ISSN: 1941-7640

Publisher: Lippincott Williams and Wilkins Ltd.

Category: Cardiology and Cardiovascular Medicine

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

3,039 Q1

H-index 122

Acceptance rate pie_chart

24% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

3,039

H-index

122

Docs (year)

154

Docs 3y

419

Total refs

3247

Cites 3y

1983

Citable 3y

309

Cites/Doc 2y

4.94

Ref/Doc

21.08

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clopidogrel Versus Aspirin as an Antiplatelet Monotherapy After 12-Month Dual-Antiplatelet Therapy in the Era of Drug-Eluting Stents

Vitronectin Concentrations Predict Risk in Patients Undergoing Coronary Stenting

Drug-Eluting Stents in Bifurcations

Doppler-Derived Intracoronary Physiology Indices Predict the Occurrence of Microvascular Injury and Microvascular Perfusion Deficits After Angiographically Successful Primary Percutaneous Coronary Intervention

Defining the Link Between Chronic Kidney Disease, High Platelet Reactivity, and Clinical Outcomes in Clopidogrel-Treated Patients Undergoing Percutaneous Coronary Intervention

Coronary Venous Interventions

Coronary Artery Revascularization in Chronic Kidney Disease

CoreValve Dislocation

Comparison of Zotarolimus- and Everolimus-Eluting Coronary Stents

Comparison of Renal Artery, Soft Tissue, and Nerve Damage After Irrigated Versus Nonirrigated Radiofrequency Ablation

Comparison of Long-Term Outcomes of Endovascular Management for Membranous and Segmental Inferior Vena Cava Obstruction in Patients With Primary Budd-Chiari Syndrome

Cluster-Randomized Clinical Trial Examining the Impact of Platelet Function Testing on Practice

SHOW MORE ARTICLES

Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder

Atherosclerotic Renal Artery Stenosis, the Oculostenotic Reflex, and Therapeutic Nihilism

Clinical Referral Patterns for Carotid Artery Stenting Versus Carotid Endarterectomy

Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3-Stent Generations

Clinical Outcomes and Safety of Transfemoral Aortic Valve Implantation Under General Versus Local Anesthesia

Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents

Change in Coronary Blood Flow After Percutaneous Coronary Intervention in Relation to Baseline Lesion Physiology

Caveat Emptor

Cardiovascular and Noncardiovascular Death After Percutaneous Coronary Intervention

Can We Improve Long-Term Outcomes Postbifurcation Stenting by Prolonged Dual Antiplatelet Therapy?

Biomarker Release After Percutaneous Coronary Intervention

Benefit of Prolonged Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stent for Coronary Bifurcation Lesions

FAQs

Circulation: Cardiovascular Interventions has an SJR of 3,039 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Circulation: Cardiovascular Interventions is 24%.

Circulation: Cardiovascular Interventions

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Circulation: Cardiovascular Interventions?

What is the APC / publication cost?

What is the acceptance rate?